Twist Bioscience Corp officer Paula Green filed a Form 144 on November 16, 2026, notifying the SEC of a proposed sale of 4,281 shares of common stock through Fidelity Brokerage Services LLC on NASDAQ.
Key Highlights
- Proposed sale: 4,281 shares of Twist Bioscience common stock with an aggregate market value of $443,890.04.
- Source of shares: The shares were acquired on November 12, 2026, through restricted stock vesting from the issuer, classified as compensation.
- Tax-related purpose: According to the filing, the sale "includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution."
- Shares outstanding: The filing lists 62,707,424 shares of common stock outstanding at the time of the notice.
- Prior sales in past 3 months: Green reported five prior sales totaling 13,656 shares, generating gross proceeds across those transactions of approximately $2,390,813.93.
- Approximate date of sale: November 16, 2026, via NASDAQ through Fidelity Brokerage Services LLC.
Twist Bioscience Officer Paula Green Files Rule 144 Notice for Restricted Stock Vesting Sale
Paula Green, identified in the filing as an officer of Twist Bioscience Corp (NASDAQ:TWST), submitted a Form 144 notice dated November 16, 2026, disclosing a proposed sale of 4,281 shares of the company's common stock. The filing states the shares were acquired on November 12, 2026, via restricted stock vesting directly from the issuer, with the nature of payment listed as compensation. The aggregate market value of the proposed sale is listed as $443,890.04.
The filing includes a remark stating that the sale "includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution." The proposed sale is to be executed through Fidelity Brokerage Services LLC, located at 900 Salem Street, Smithfield, RI 02917, on NASDAQ. The form was signed by Jennifer Ruchti as a duly authorized representative of Fidelity Brokerage Services LLC, acting as attorney-in-fact for Paula Green.
Green's Form 144 also discloses five sales of Twist Bioscience common stock during the prior three months. Those transactions occurred on August 21, 2026 (1,360 shares, $189,130.30), September 8, 2026 (907 shares, $111,219.88), September 21, 2026 (294 shares, $48,654.47), October 2, 2026 (10,088 shares, $1,905,459.77), and November 3, 2026 (1,007 shares, $136,349.51), all listed at the issuer's address of 681 Gateway Blvd, South San Francisco, CA 94080.
What Was Disclosed
Twist Bioscience officer Paula Green filed a Form 144 notice proposing to sell 4,281 shares of common stock acquired through restricted stock vesting on November 12, 2026, with the sale attributed in part to covering a tax obligation related to the equity award settlement.



Please wait processing your request...